ctDNA as a predictive biomarker in advanced breast cancer: Lessons from the MONALEESA studies
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference26 articles.
1. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis;Gao;Lancet Oncol,2020
2. Circulating tumor DNA in breast cancer: a biomarker for patient selection;Agostinetto;Curr Opin Oncol,2023
3. Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials;André;Ann Oncol,2023
4. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants;Razavi;Nat Med,2019
5. Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer;O’Leary;JNCI J Natl Cancer Inst,2021
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating tumor DNA validity and potential uses in metastatic breast cancer;npj Breast Cancer;2024-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3